uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neurokemiska visioner: Cipramil och farmakaliseringen av depressionssjukdomar 1988–2002
Uppsala University, Disciplinary Domain of Humanities and Social Sciences, Faculty of Arts, Department of History of Science and Ideas.
2017 (Swedish)Independent thesis Advanced level (degree of Master (Two Years)), 30 credits / 45 HE creditsStudent thesis
Abstract [en]

The history of pharmaceuticals often tends to be the history of chemistry, scientists, and

successful invention. In Sweden, discussions regarding the history of modern antidepressants

often demonstrate a lack of historical perspectives.

This thesis aims at showing the importance of acknowledging the more social aspects of

pharmaceutical history. By focusing on the SSRI Cipramil, and how it rose to success in

Sweden, accentuated by the pharmaceutical company H. Lundbeck AB as a safe and modern

antidepressant, it becomes clear that there is more to it than the chemical substance and new

neurochemical knowledge.

What follows is a history of pharmaceuticalisation and co-production. The study begins

in the year 1988 and continues to 2002, identifying three different strands in the process of

pharmaceuticalisation. The first part is regarding the renegotiation of medical knowledge in

the applications to the Swedish Medical Products Agency. The second about how the trope of

a chemical imbalance in the brain took hold and was made a premise for the use of the new

SSRIs, and the third about how depression was reshaped into a neurochemical, uniform

disease, where everyone was at risk.

In conclusion, the thesis provides an example of how, through co-production, the

pharmaceuticalisation of mental illness took place in Sweden and continues to this day.

Place, publisher, year, edition, pages
2017. , 92 p.
Keyword [en]
Pharmaceuticals, Pharmaceutical companies, Pharmaceuticalisation, farmakalisering, Co-production, Depression, SSRI, neurochemistry, chemical imbalance theory, Sweden
National Category
History of Ideas
Identifiers
URN: urn:nbn:se:uu:diva-323074OAI: oai:DiVA.org:uu-323074DiVA: diva2:1104827
Subject / course
History of Science and Ideas
Educational program
Master Programme in the Humanities – History of Science and Ideas
Supervisors
Examiners
Available from: 2017-06-16 Created: 2017-06-02 Last updated: 2017-06-16Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of History of Science and Ideas
History of Ideas

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 147 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf